Simone Kreth (S Kreth)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Long Noncoding Rna

Top Venues

Science translational medicine

Molecular medicine (Cambridge, Mass.)

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tim Rahmel, David Effinger, Thilo Bracht, Leonore Griep, Björn Koos, Barbara Sitek, Max Hübner, Simon Hirschberger, Jale Basten, Nina Timmesfeld, Michael Adamzik, Simone Kreth
An open-label, randomized controlled trial to assess a ketogenic diet in critically ill patients with sepsis. Science translational medicine 16 (755) (2024)
Tim Rahmel, David Effinger, Thilo Bracht, Leonore Griep, Björn Koos, Barbara Sitek, Max Hübner, Simon Hirschberger, Jale Basten, Nina Timmesfeld, Michael Adamzik, Simone Kreth
An open-label, randomized controlled trial to assess a ketogenic diet in critically ill patients with sepsis. Science translational medicine 16 (755) (2024)
Simon Hirschberger, Gabriele Strauß, David Effinger, Xaver Marstaller, Alicia Ferstl, Martin B Müller, Tingting Wu, Max Hübner, Tim Rahmel, Hannah Mascolo, Nicole Exner, Julia Heß, Friedrich W Kreth, Kristian Unger, Simone Kreth
Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogramming. EMBO molecular medicine 13 (8) (2021)
P Möhnle, S Hirschberger, L C Hinske, J Briegel, M Hübner, S Weis, G Dimopoulos, M Bauer, E J Giamarellos-Bourboulis, Simone Kreth
MicroRNAs 143 and 150 in whole blood enable detection of T-cell immunoparalysis in sepsis. Molecular medicine (Cambridge, Mass.) 24 (1) (2018)